HIV-Associated Lipodystrophy Syndrome

Known as: Lipodystrophy, HIV-Associated, Lipodystrophy Syndrome, HIV-Associated, Lipodystrophy Syndrome, HIV 
Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2017
051019992017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Patients with HIV-associated dyslipidemic lipodystrophy (HADL) have characteristic lipid kinetic defects: accelerated lipolysis… (More)
Is this relevant?
2008
2008
PURPOSE Treatment options for HIV-associated lipodystrophy syndrome (HALS) remain limited. The objective of this randomized open… (More)
Is this relevant?
2006
2006
In recent years, lipodystrophy and its related complications have become one of the major problems confronting HIV-infected… (More)
Is this relevant?
2006
2006
BACKGROUND HIV-associated lipodystrophy syndrome (LDS) as a long-term side effect of HAART is becoming increasingly important and… (More)
Is this relevant?
2005
2005
BACKGROUND PAI-1, an important inhibitor of fibrinolysis, is increased in obese subjects and has been shown to be an independent… (More)
Is this relevant?
2005
2005
BACKGROUND The pathogenesis of hypertriacylglycerolemia, a characteristic feature of HIV lipodystrophy syndrome (HLS), is… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2004
2004
The widespread use of highly active antiretroviral therapy (HAART) has radically transformed the prognosis of HIV-infected… (More)
Is this relevant?
2002
2002
OBJECTIVE To identify prevalence and risk factors associated with the HIV-associated lipodystrophy syndrome (HIVLD) after 3 years… (More)
Is this relevant?
2001
2001
BACKGROUND Diagnosis of the HIV-associated lipodystrophy syndrome is based on clinical assessment, in lack of a consensus about… (More)
Is this relevant?
Review
2000
Review
2000
Highly active antiretroviral therapy (HAART) for human immunodeficiency virus-1 (HIV-1) and prophylactic therapy for… (More)
Is this relevant?